Adtalem Global Education Inc. Earnings Recaps
Q2 2026
Jan 29, 2026
Adtalem Global Education Inc. delivered strong second-quarter results, achieving record enrollments and revenue growth while raising earnings guidance for the year, reflecting a robust execution of its strategic roadmap.
Key takeaways
- Total enrollment grew over 6% to 97,000 students, with revenue increasing 12% to $503 million.
- Adjusted earnings per share rose 34% year-over-year to $2.43, prompting a raise in the full-year growth guidance to 17% to 20%.
- Chamberlain's nursing programs maintained a strong market position with a temporary pause in enrollment expected to rebound entering fall.
- Walden's enrollment reached a record of 52,400 students, marking the tenth consecutive quarter of growth, driven by innovative online offerings.
- A disciplined capital allocation approach saw $165 million dedicated to share repurchases this quarter, with $728 million remaining under authorization.
Q4 2025
Aug 8, 2025
Adtalem Global Education reported robust financial performance for fiscal year 2025, achieving significant revenue growth and strategic advancements in enrollment and student outcomes amidst a challenging educational landscape.
Key takeaways
- Revenue rose to $1.79 billion, a 12.9% increase year-over-year, driven by over 10% average enrollment growth across all segments.
- Adjusted EBITDA margin expanded by 190 basis points to 25.7%, with adjusted earnings per share up 33% to $6.67.
- Generated $283 million in free cash flow while reducing Term Loan B by $100 million and decreasing borrowing costs by 75 basis points.
- Successful partnerships, particularly with SSM Health, enhance direct employment pathways for students and align education more closely with workforce needs.
- Recognition from the Carnegie Foundation highlights Adtalem's commitment to access and positive post-graduation outcomes in the health care sector.